Eighteen cannabis workers at the Sunnyside dispensary in Wyomissing, Pennsylvania, forced a major concession from their employer. They ended a 20-day strike on Mar. 17 and returned to work with a significantly improved contract.
Teamsters Local 429 members launched the walkout on Feb. 26 after months of stalled negotiations. They demanded better pay, solid health coverage and more respect in a high-turnover industry where budtenders often leave for better opportunities elsewhere.
The new agreement delivers clear gains, according to a news release from the union. Workers will now receive a 12.5 per cent wage increase, upgraded health-care benefits, extra paid time off and stronger protections against unjust discipline or termination. Part-time employees are set to gain enhanced job security that prevents arbitrary scheduling changes, as specified by Teamsters.
These changes address long-standing complaints about low compensation and unstable conditions. Issues like these plague retail cannabis jobs nationwide.
Union leaders credit the workers’ solidarity for turning the tide. One wellness advisor at the store noted that the deal finally makes employees feel valued in their roles.
“For the first time, I feel like we are respected and our future is secure,” said Sunnyside employee Cobi Motley.
This victory marks the second successful Teamsters strike at a Pennsylvania cannabis retailer in recent months. It follows a 45-day action at a Green Thumb Industries Inc (CNSX: GTII) (OTCMKTS: GTBIF) location last fall.
Cresco Labs Inc (CNSX: CL) (OTCMKTS: CRLBF) (FRA: 6CQ), the Chicago-based owner of the Sunnyside brand, operates as one of the country’s largest publicly traded multi-state operators. Founded in 2013, the vertically integrated company cultivates, manufactures and sells branded products across eight states.
It runs dozens of dispensaries under the Sunnyside banner and holds a top position in Pennsylvania’s market.
Cresco has expanded its Pennsylvania footprint recently, including through a new store that opened in Beaver Falls last year.
Pennsylvania’s cannabis market remains one of the nation’s strongest medical-only programs. Launched in 2016, it now serves roughly 439,000 registered patients and generates nearly US$2 billion in annual sales.
Lawmakers continue to debate adult-use legalization, which analysts say could add nearly half a billion in new state revenue by 2028.
Read more: Unionized workers at Cresco Labs dispensary in Pennsylvania go on strike
Follow Rowan Dunne on LinkedIn
rowan@mugglehead.com
